相关实验视频
Updated: May 6, 2026

07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
19.6K
基于机器学习的转录基因分析确定了败血症诱导的凝血病候选基因,并探讨了贝卡林的免疫调节潜力
Lifang Mu1,2, Yuxue Zhang1,2, Tingting Yuan1,2
1Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China.
Human genomics
|August 31, 2025
概括
这项研究确定了MMP9,ARG1和FYN作为败血症相关凝血障碍的关键基因. 通过与这些免疫调节基因相互作用,Baicalein具有治疗潜力.
科学领域:
- 生物化学
- 分子生物学
- 基因组学
背景情况:
- 败血症显著增加患病率和死亡率,经常导致凝血障碍.
- 拜卡莱因具有抗炎作用,是潜在的败血症治疗方法,但其在败血症相关的凝血障碍中的机制尚不清楚.
研究的目的:
- 为了研究贝卡莱因在败血症中的治疗效果.
- 鉴定与败血症相关的凝血障碍中涉及贝卡林作用机制的候选基因.
主要方法:
- 分析了转录组数据,贝卡莱因标和凝血障碍基因.
- 机器学习和表达验证确定了候选基因 (MMP9,ARG1,FYN).
- 分子对接评估了白蛋白相互作用;RT-qPCR验证了基因表达.
主要成果:
- 确认MMP9,ARG1和FYN是败血症的候选基因.
- 通过这些基因开发出用于败血症诊断的预测性名录.
- 拜卡莱因与这些基因编码的蛋白质具有强烈的结合相互作用.
结论:
- MMP9,ARG1和FYN被确定为败血症中的关键基因,参与免疫调节.
- 通过与这些已识别的基因相互作用,Baicalein显示出对败血症的治疗潜力.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129

